Skip to main content

Skin Quality

2
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
2 programs
1
1
NOA HYDRATIONPhase 31 trial
Hyper-Diluted BotoxPhase 21 trial
Active Trials
NCT03097835Completed15Est. Jul 2018
NCT07880756Recruiting150Est. Feb 2028
Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
1 program
1064NM pico LaserN/A1 trial
Active Trials
NCT05595525Unknown20Est. Jun 2023
KiOmed Pharma
KiOmed PharmaBelgium - Liège
1 program
KIO015N/A1 trial
Active Trials
NCT05747690Completed78Est. May 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
AbbVieNOA HYDRATION
AbbVieHyper-Diluted Botox
KiOmed PharmaKIO015
Fitzpatrick Company1064NM pico Laser

Clinical Trials (4)

Total enrollment: 263 patients across 4 trials

NCT07880756AbbVieNOA HYDRATION

Safety and Effectiveness of NOA HYDRATION Injectable Gel for the Improvement of Skin Quality Including Attributes Such as Skin Smoothness

Start: Sep 2026Est. completion: Feb 2028150 patients
Phase 3Recruiting
NCT03097835AbbVieHyper-Diluted Botox

Evaluation of Skin Quality Improvement

Start: Feb 2018Est. completion: Jul 201815 patients
Phase 2Completed
NCT05747690KiOmed PharmaKIO015

Evaluation of Performance and Safety of KIO015 in Face Tissue Filling

Start: Jan 2023Est. completion: May 202478 patients
N/ACompleted
NCT05595525Fitzpatrick Company1064NM pico Laser

Laser Treatment to Improve Skin Quality

Start: Nov 2022Est. completion: Jun 202320 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 263 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.